These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 25881840)
1. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Park JS; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK Medicine (Baltimore); 2015 Apr; 94(15):e658. PubMed ID: 25881840 [TBL] [Abstract][Full Text] [Related]
2. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases. Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126 [TBL] [Abstract][Full Text] [Related]
5. Survival after curative resection for stage I colorectal mucinous adenocarcinoma. Huang L; Luo S; Lai S; Liu Z; Hu H; Chen M; Kang L BMC Gastroenterol; 2022 Apr; 22(1):192. PubMed ID: 35436867 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy. Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310 [TBL] [Abstract][Full Text] [Related]
7. Inverse effect of mucinous component on survival in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953 [TBL] [Abstract][Full Text] [Related]
8. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Nitsche U; Zimmermann A; Späth C; Müller T; Maak M; Schuster T; Slotta-Huspenina J; Käser SA; Michalski CW; Janssen KP; Friess H; Rosenberg R; Bader FG Ann Surg; 2013 Nov; 258(5):775-82; discussion 782-3. PubMed ID: 23989057 [TBL] [Abstract][Full Text] [Related]
9. Predictors of Lymph Node Metastasis and Prognosis in pT1 Colorectal Cancer Patients with Signet-Ring Cell and Mucinous Adenocarcinomas. Song BR; Xiao CC; Wu ZK Cell Physiol Biochem; 2017; 41(5):1753-1765. PubMed ID: 28365687 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Laparoscopic Surgery for Mucinous Colorectal Adenocarcinoma. Huang Q; Zou MH; Jiang Y; Chen ZP; Wang Q; Wei JC; Li WL; Cao J J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):638-647. PubMed ID: 33151807 [No Abstract] [Full Text] [Related]
11. [Clinical features of colorectal mucinous adenocarcinoma]. Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341 [TBL] [Abstract][Full Text] [Related]
12. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer? Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874 [TBL] [Abstract][Full Text] [Related]
13. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. Verhulst J; Ferdinande L; Demetter P; Ceelen W J Clin Pathol; 2012 May; 65(5):381-8. PubMed ID: 22259177 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma. Han F; Xu Y; Li X; Song Z; Xie J; Yao J Sci Rep; 2024 Aug; 14(1):18682. PubMed ID: 39134655 [TBL] [Abstract][Full Text] [Related]
15. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study. Wu X; Lin H; Li S BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167 [TBL] [Abstract][Full Text] [Related]
16. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer. Yoon YS; Kim J; Hong SM; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC Colorectal Dis; 2015 Aug; 17(8):O161-7. PubMed ID: 26095997 [TBL] [Abstract][Full Text] [Related]
17. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A Digestion; 2018; 98(3):143-152. PubMed ID: 29870979 [TBL] [Abstract][Full Text] [Related]
18. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma. Barresi V; Reggiani Bonetti L; Ieni A; Domati F; Tuccari G Hum Pathol; 2015 Nov; 46(11):1722-9. PubMed ID: 26344416 [TBL] [Abstract][Full Text] [Related]
20. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy. Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]